Zuora, Inc. (ZUO) — Earnings Call X-Ray
Our AI read all 26 of ZUO's earnings calls (2018–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
B+
Q1 2025
Calls Analyzed
26
2018–2024
Avg Candor
6.5/9
evasion 2.5/9
Call-by-call analysis
🔒 Q2 2025 earnings call
2024-08-21
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q2 2025 call grade is ready
The full 37-point AI read of ZUO's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
B+
Q1 2025 earnings call
2024-05-22
move ±10.3%
Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: raisedDemand: mixedMargins: expandingBacklog: growingPricing: stableHeadcount: flatCapex: flat 5 analysts · 9 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
D
Q4 2023 earnings call
2024-02-28
move ±13.5%
Management lowered guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: loweredDemand: mixedMargins: expandingBacklog: growingPricing: stableHeadcount: cuttingCapex: flat 6 analysts · 12 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B
Q3 2024 earnings call
2023-11-29
move ±15.7%
Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics.
Guidance: raisedDemand: stableMargins: expandingBacklog: growingPricing: stableCapex: flat 7 analysts · 12 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
B+
Q2 2024 earnings call
2023-08-23
move ±18.6%
Management raised guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.
Guidance: raisedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: flatCapex: flat 8 analysts · 17 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growingFounder-led
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q1 2024 earnings call
2023-05-24
move ±25%
Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics.
Guidance: raisedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: flat 8 analysts · 15 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q4 2023 earnings call
2023-03-01
move ±25.3%
Management lowered guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: loweredDemand: mixedMargins: expandingBacklog: growingPricing: stableHeadcount: cuttingCapex: flat 7 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthFounder-led
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO
D
Q3 2023 earnings call
2022-12-06
move ±29.1%
Management lowered guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: loweredDemand: slowingMargins: expandingBacklog: growingPricing: stableHeadcount: cuttingCapex: flat 5 analysts · 12 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Early product, fast growthFounder-ledCFO dominates
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q2 2023 |
2022-08-24 |
C+ |
lowered | stable | expanding |
7/9 |
2/9 |
| Q1 2023 |
2022-05-25 |
C+ |
maintained | stable | expanding |
6/9 |
3/9 |
| Q4 2022 |
2022-03-02 |
B |
raised | accelerating | expanding |
5/9 |
3/9 |
| Q3 2022 |
2021-12-01 |
A |
raised | accelerating | expanding |
7/9 |
1/9 |
| Q2 2022 |
2021-08-25 |
B |
raised | accelerating | contracting |
6/9 |
2/9 |
| Q1 2022 |
2021-05-26 |
B |
raised | accelerating | expanding |
6/9 |
3/9 |
| Q4 2021 |
2021-03-11 |
C |
maintained | accelerating | expanding |
6/9 |
2/9 |
| Q3 2021 |
2020-12-03 |
C+ |
maintained | stable | expanding |
6/9 |
3/9 |
| Q2 2021 |
2020-09-02 |
D |
maintained | mixed | expanding |
7/9 |
3/9 |
| Q1 2021 |
2020-06-03 |
D |
withdrawn | stable | expanding |
7/9 |
3/9 |
| Q4 2020 |
2020-03-12 |
D |
maintained | mixed | stable |
7/9 |
4/9 |
| Q3 2020 |
2019-12-05 |
D |
maintained | stable | expanding |
6/9 |
3/9 |
| Q2 2019 |
2019-08-28 |
C+ |
maintained | stable | expanding |
7/9 |
2/9 |
| Q1 2020 |
2019-05-30 |
D |
lowered | mixed | stable |
8/9 |
2/9 |
| Q4 2019 |
2019-03-22 |
B |
maintained | accelerating | stable |
7/9 |
2/9 |
| Q3 2019 |
2018-11-29 |
B+ |
raised | accelerating | expanding |
6/9 |
2/9 |
| Q2 2019 |
2018-08-31 |
A |
raised | accelerating | expanding |
6/9 |
2/9 |
| Q1 2019 |
2018-05-31 |
B |
raised | stable | contracting |
5/9 |
2/9 |
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← ZUMZ All “Z” companies
ZURVY →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.